Voxsanity

Who may be able to join

Who might be able to join this trial:

You have been diagnosed with type 1 diabetes that is considered well controlled, but you still experience about 2 to 3 low blood sugar episodes per week.
You are between 18 and 50 years old.
Your body mass index (BMI — a measure based on your height and weight) is between 18 and 30.

Who may not be able to join:

You are currently pregnant.
You have serious complications related to your diabetes.
You have liver disease or cirrhosis (scarring of the liver).
You have a heart or cardiac condition.
You have a neurological disorder (a condition affecting the brain or nervous system).
You have autonomic neuropathy (a type of nerve damage that affects automatic body functions like heart rate or digestion — confirm with trial site).
You have kidney disease.
You have lactose intolerance (difficulty digesting dairy products).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status

Completed

Phase

Not Applicable

Sponsor

Yale University

Registry

clinicaltrials_gov

Start date

1 August 2010

Est. completion

1 August 2014

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Glucagon (pg/mL); Epinephrine (pg/mL); Norepinephrine (pg/mL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov